Prophylactic cranial irradiation: going, going, gone

The Lancet Oncology

Volumn 10, Issue 10, 2009, Pages 932-933

  Pui, Ching Hon ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL 1 PROTEIN; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DEXAMETHASONE; METHOTREXATE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE NECROSIS; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; DRUG MEGADOSE; EVENT FREE SURVIVAL; HIGH RISK PATIENT; HUMAN; INFECTION; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SKULL IRRADIATION;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CLINICAL PROTOCOLS; DISEASE-FREE SURVIVAL; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 70349385648     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70239-6     Document Type: Letter

References (5)

1. Veerman A.J., Kamps W.A., van den Berg H., et al., for the Dutch Childhood Oncology Group. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol (2009) 10.1016/S1470-2045(09)70228-1 published online Sept 10.
2. Pui C-H, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia. Leukemia (in press).
3. Pui C.-H., Campana D., Pei D., et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360 (2009) 2730-2741
4. Schrappe M., Zimmermann M., Möricke A., et al. Dexamethasone in induction can eliminate one third of all relapses in childhood acute lymphoblastic leukemia (ALL): results of an international randomized trial in 3655 patients (trial AIEOP-BFM ALL 2000). Blood 112 (2008) 9 (abstr).
5. Schultz KR, Bowman WP, Aledo A, et al. Improved early event free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol (in press).